Doctor profile · Federal record
Dr. Susan Elrod, APRN
Nurse Practitioner · Louisville, KY
- NPI 1063418713
- Accepts Medicare
- MIPS 62.1 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3810 Springhurst Blvd Ste 200
Louisville, KY 40241
(502) 583-1749
fax (502) 329-8184 - Mailing address
-
Po Box 950132
Louisville, KY 402950132
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- July 17, 2018
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Indiana #71001220A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1063418713. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,533
Distinct HCPCS
10
Medicare allowed
$144,415
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,377 | 246 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 808 | 563 | $71 | |
17000 |
Destruction of precancer skin growth, 1 growth | 469 | 322 | $39 | |
17110 |
Destruction of skin growth, 1-14 growths | 390 | 297 | $87 | |
11102 |
Biopsy of related skin growth, first growth | 147 | 132 | $63 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 81 | 18 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 75 | 69 | $45 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 73 | 73 | $88 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 42 | 32 | $101 | |
96372 |
Injection of drug or substance under skin or into muscle | 21 | 16 | $11 |
In context: peer comparison
Among 136 peers in Louisville Nurse Practitioner, average services per provider: 136. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$2,077
Transactions
96
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 25 | $425.51 | |
| Regeneron Healthcare Solutions, INC. | 11 | $339.18 | |
| Novartis Pharmaceuticals Corporation | 10 | $294.19 | |
| E.R. Squibb & Sons, L.L.C. | 18 | $292.74 | |
| Amgen INC. | 4 | $167.07 | |
| Ucb, INC. | 5 | $142.03 | |
| Janssen Biotech, INC. | 5 | $93.96 | |
| Lilly USA, LLC | 5 | $91.03 | |
| Galderma Laboratories, L.P. | 6 | $91.02 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $48.88 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 2 | $40.62 | |
| Kyowa Kirin, INC. | 2 | $34.38 | |
| Pfizer INC. | 1 | $16.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
711
Patients
359
Total drug cost
$349,064
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 132 | 91 | $1,757 |
| Ketoconazole | Generic | 82 | 36 | $1,317 |
| Hydrocortisone | Generic | 78 | 54 | $1,071 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 63 | 36 | $2,863 |
| Clobetasol Propionate | Generic | 57 | 32 | $4,327 |
| Doxycycline Hyclate | Generic | 54 | 23 | $2,015 |
| Hydroxyzine Hcl | Generic | 42 | 11 | $639 |
| Otezla (Apremilast) | Brand | 34 | 0 | $160,427 |
| Metronidazole | Generic | 32 | 20 | $2,917 |
| Imiquimod | Generic | 26 | 20 | $654 |
Frequently asked questions
What is Dr. Susan Elrod's medical specialty?
Dr. Susan Elrod practices Nurse Practitioner in Louisville, KY.
Where does Dr. Susan Elrod practice?
Dr. Susan Elrod practices at 3810 Springhurst Blvd Ste 200, Louisville, KY 40241. Office phone: 5025831749.
What is Dr. Susan Elrod's NPI?
Dr. Susan Elrod's National Provider Identifier (NPI) is 1063418713, issued by NPPES.
Does Dr. Susan Elrod accept Medicare assignment?
Yes. Dr. Susan Elrod accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Susan Elrod commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.